Riluzole for Cervical Myelopathy
JAMA Network Open · 2024
DOI: 10.1001/jamanetworkopen.2024.15616 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Network Open, 2024. Verfasst von Zoher Ghogawala. Beteiligte Einrichtung: Department of Neurosurgery, Lahey Hospital and Medical Center, Burlington, Massachusetts. Hauptthemen laut MEDLINE: Riluzole, Spinal Cord Diseases, Cervical Vertebrae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Michael G. Fehlings, MD, PhD; Karlo M. Pedro, MD; Mohammed Ali Alvi, MD; Jetan H. Badhiwala, MD, PhD; Henry Ahn, MD; H. Francis Farhadi, MD; Christopher I. Shaffrey, MD; Ahmad Nassr, MD; Praveen Mummaneni, MD; Paul M. Arnold, MD; W. Bradley Jacobs, MD; K. Daniel Riew, MD; Michael Kelly, MD; Darrel S. Brodke, MD; Alexander R. Vaccaro, MD; Alan S. Hilibrand, MD; Jason Wilson, MD; James S. Harrop, MD; S. Tim Yoon, MD; Kee D. Kim, MD; Daryl R. Fourney, MD; Carlo Santaguida, MD; Eric M. Massicotte, MD; Peng Huang, PhD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Lahey Hospital and Medical Center, Burlington, Massachusetts.
- Tufts University School of Medicine, Boston, Massachusetts.
Zitieren
APA
Ghogawala, Z. (2024). Riluzole for Cervical Myelopathy. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.15616
Vancouver
Ghogawala Z. Riluzole for Cervical Myelopathy. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.15616
BibTeX
@article{Ghogawala2024,
author = {Ghogawala, Zoher},
title = {Riluzole for Cervical Myelopathy},
journal = {JAMA Network Open},
year = {2024},
doi = {10.1001/jamanetworkopen.2024.15616}
}
EUVIMED